Management of constipation in the elderly: Emerging therapeutic strategies

World Journal of Gastroenterology

Volumn 14, Issue 33, 2008, Pages 5226-5227

  Kapoor, Shailendra ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Constipation; Lubiprostone; Methylnaltrexone; Neostigmine; Prucalopride

Indexed keywords

17 METHYLNALTREXONE; BOTULINUM TOXIN; LUBIPROSTONE; NEOSTIGMINE; PRUCALOPRIDE; BENZOFURAN DERIVATIVE; DRUG DERIVATIVE; PROSTAGLANDIN E1;

CONSTIPATION; DEFECATION HABIT; DRUG APPROVAL; DRUG EFFICACY; ELDERLY CARE; FOOD AND DRUG ADMINISTRATION; HUMAN; LETTER; LUMBOSACRAL PLEXUS; NERVE STIMULATION; QUALITY OF LIFE; TREATMENT RESPONSE; AGE; AGED; NOTE;

AGE FACTORS; AGED; AGED, 80 AND OVER; ALPROSTADIL; BENZOFURANS; CONSTIPATION; HUMANS; NEOSTIGMINE;

EID: 58149235371     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.14.5226     Document Type: Letter

References (10)

1. McCrea GL, Miaskowski C, Stotts NA, Macera L, Varma MG. Pathophysiology of constipation in the older adult. World J Gastroenterol 2008; 14: 2631-2638
2. Camilleri M, Kerstens R, Rykx A, Vandeplassche L. A placebo-controlled trial of prucalopride for severe chronic constipation. N Engl J Med 2008; 358: 2344-2354
3. Johanson JF, Drossman DA, Panas R, Wahle A, Ueno R. Clinical trial: phase 2 study of lubiprostone for irritable bowel syndrome with constipation. Aliment Pharmacol Ther 2008; 27: 685-696
4. Rubiales AS, Hernansanz S, Gutierrez C, Del Valle ML, Flores LA. Neostigmine for refractory constipation in advanced cancer patients. J Pain Symptom Manage 2006; 32: 204-205
5. De Paula JA, Carmuega E, Weill R. Effect of the ingestion of a symbiotic yogurt on the bowel habits of women with functional constipation. Acta Gastroenterol Latinoam 2008; 38: 16-25
6. Portenoy RK, Thomas J, Moehl Boatwright ML, Tran D, Galasso FL, Stambler N, Von Gunten CF, Israel RJ. Subcutaneous methylnaltrexone for the treatment of opioid-induced constipation in patients with advanced illness: a double-blind, randomized, parallel group, dose-ranging study. J Pain Symptom Manage 2008; 35: 458-468
7. Traynor K. Relistor approved for opioid-related constipation. Am J Health Syst Pharm 2008; 65: 996
8. Lee KJ, Kim JH, Cho SW. Short-term effects of magnetic sacral dermatome stimulation for idiopathic slow transit constipation: sham-controlled, cross-over pilot study. J Gastroenterol Hepatol 2006; 21: 47-53
9. Mowatt G, Glazener C, Jarrett M. Sacral nerve stimulation for fecal incontinence and constipation in adults: a short version Cochrane review. Neurourol Urodyn 2008; 27: 155-161
10. Irani K, Rodriguez L, Doody DP, Goldstein AM. Botulinum toxin for the treatment of chronic constipation in children with internal anal sphincter dysfunction. Pediatr Surg Int 2008; 24: 779-783